Ranitidine and Thiotepa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine (ranitidine) and Thiotepa (thiotepa). Common drug interactions include pain among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine and Thiotepa. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Thiotepa?

Thiotepa has active ingredients of thiotepa. eHealthMe is studying from 8,097 Thiotepa users. Check the latest studies of Thiotepa.



On Aug, 12, 2026

59 people who take Ranitidine and Thiotepa together, and have interactions are studied.

Ranitidine and Thiotepa drug interactions.

What are the common drug interactions of Ranitidine and Thiotepa, by gender? *:

female:

  1. Pain
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Rash erythematous (redness of the skin)
  4. Visual impairment
  5. Diarrhoea
  6. Gamma-glutamyltransferase increased
  7. Hypokalaemia (low potassium)
  8. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  9. Hypotension (abnormally low blood pressure)
  10. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

male:

  1. Diarrhoea
  2. Mucosal inflammation (infection of mucous membrane)
  3. Presyncope
  4. Pyrexia (fever)
  5. Respiratory distress (difficulty in breathing)
  6. Venoocclusive liver disease (small veins in the liver are obstructed)
  7. Vomiting
  8. Multi-organ failure (multisystem organ failure)
  9. Abdominal distension
  10. Alopecia (absence of hair from areas of the body)

What are the common drug interactions of Ranitidine and Thiotepa, by age (0-1 to 60+)? *:

0-1:

  1. Abdominal distension
  2. Alopecia (absence of hair from areas of the body)
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Candidiasis (candidiasis or thrush is a fungal infection)
  5. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  6. Failure to thrive (inadequate weight gain and physical growth in children)
  7. Fluid overload (too much fluid in the blood)
  8. Gastroenteritis (inflammation of stomach and intestine)
  9. Hypertension (high blood pressure)
  10. Hypotension (abnormally low blood pressure)

2-9:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  2. Bacteraemia (presence of bacteria in the blood)
  3. Epstein-barr virus infection
  4. Diarrhoea
  5. Aplasia (defective development or congenital absence of an organ or tissue)
  6. Epistaxis (bleed from the nose)
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Thrombocytopenia (decrease of platelets in blood)
  9. Acute respiratory failure
  10. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)

10-19:

  1. Presyncope
  2. Abdominal pain
  3. Acute respiratory failure
  4. Aplasia (defective development or congenital absence of an organ or tissue)
  5. Cytomegalovirus infection
  6. Diarrhoea
  7. Epistaxis (bleed from the nose)
  8. Pulmonary mass
  9. Vomiting
  10. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)

20-29:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Cardiac arrest
  3. Enteritis (inflammation of the small intestine)
  4. Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
  5. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  6. Mucosal inflammation (infection of mucous membrane)
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Abdominal pain
  9. Central line infection (infection by central line in icu)
  10. Diarrhoea

30-39:

n/a

40-49:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Cystitis haemorrhagic (blood in the urine and painful voiding)
  3. Diarrhoea
  4. Drug clearance increased
  5. Drug level below therapeutic
  6. Haematuria present (presence of blood in urine due to trauma)
  7. Mucosal inflammation (infection of mucous membrane)
  8. Scar
  9. Stem cell transplant

50-59:

  1. Pyrexia (fever)
  2. Renal failure acute (rapid kidney dysfunction)
  3. Capillaritis (inflamed capillaries under the skin)
  4. Hepatitis (inflammation of the liver)
  5. Mucosal inflammation (infection of mucous membrane)

60+:

  1. Blood creatinine decreased
  2. Creatinine renal clearance increased
  3. Faecal incontinence (a lack of control over passing stool)
  4. Muscular weakness (muscle weakness)
  5. Oedema peripheral (superficial swelling)
  6. Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years)
  7. Urinary incontinence (inability to control the flow of urine and involuntary urination)

What are the existing conditions these people have? *

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 19 people, 32.20%
  2. Nervous System Disorder (a general class of medical conditions affecting the nervous system): 7 people, 11.86%
  3. Drug Dependence: 5 people, 8.47%
  4. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 6.78%
  5. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 5.08%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and Thiotepa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ranitidine and Thiotepa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Thiotepa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thiotepa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine and thiotepa (the active ingredients of Ranitidine and Thiotepa, respectively), and Ranitidine and Thiotepa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: